期刊文献+

口服抗凝药的最佳时机 被引量:1

下载PDF
导出
摘要 研究人员对静脉血栓形成首次发作后口服抗凝药治疗的最佳期限仍存在争议。在一项开放性的随机试验中,研究人员对短期口服抗凝治疗(近端深静脉血栓[P-DVT]和/或肺栓塞[PE]治疗3个月、孤立的腓肠肌DVT[C-DVT]治疗6周)与长期治疗过程(P-DVT/PE治疗6个月、C-DVT治疗12周)的效果进行了比较。终点事件是复发以及严重的、轻度的或致死性出血并发症。本项研究共有736人入选。
作者 王璐
出处 《国外医学情报》 2002年第9期24-24,共1页 foreign medical information
  • 相关文献

同被引文献21

  • 1AnsellJ. HirshJ. Hylek E. et al . Pharmacology and man?agement of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition iJ J]. Oiest .2008. 133(6 Suppl) , 1608-198S.
  • 2PicciniJP. Hernandez AF. Zhao X. et al. Quality of care for atrial fibrillation among patients hospitalized for heart failure[J].J Am Call Cardiol ,2009, 54(14): 1280-1289.
  • 3Mousa , S. A. Oral direct factor X a inhibitors, with special emphasis on rivaroxaban[J]. Methods Mol Biol ,2010, 663: 181-201.
  • 4Lam S. Apixaban . a new factor X a inhibitor for stroke pre?vention in patients with nonvalvular atrial fibrillation[J]. Cardiol Rev ,2013, 21(4) :207-212.
  • 5StangierJ. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate[J]. Gin Pharmacakinet ,2008, 47(5): 285-295.
  • 6De Caterina, R Kristensen. G Renda. New anticoagulants for atrial fibrillation[J].J Cardiovasc Med (Hagerstown), 2009,10(6): 446-453.
  • 7Keisu M, TB Andersson. Drug-induced liver injury in hu?mans: the case of ximeiagatranDJ. Handb Exp Pharmacal, 2010, 196(4): 407-418.
  • 8Connolly SJ. Ezekowitz MD, Yusuf S. et al . Dabigatran ver?sus warfarin in patients with atrial fibrillation]"]]. N EnglJ Med, 2009, 361(12): 1139-1151.
  • 9Gage, B. F. Can we rely on RE-LY[J]. N EnglJ Med , 2009, 361 (12): 1200-1202.
  • 10Connolly SJ, Ezekowitz MD, Yusuf S, et al . Newly identified events in the RE-L Y trial[J]. N EnglJ Med , 2010,363 (19): 1875-1876.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部